作者
Paul A. Friedman,Francis Murgatroyd,Lucas V.A. Boersma,Jaimie Manlucu,David O’Donnell,Bradley P. Knight,Nicolas Clémenty,Christophe Leclercq,Anish K. Amin,Béla Merkely,Ulrika Birgersdotter‐Green,Joseph Yat‐Sun Chan,Mauro Biffi,Reinoud E. Knops,Gregory S. Engel,Ignacio Muñoz Carvajal,Laurence M. Epstein,Venkata Sagi,Jens Brock Johansen,Maciej Sterliński,Clemens Steinwender,Troy Hounshell,Richard Abben,Amy Thompson,Christopher Wiggenhorn,Sarah Willey,Ian Crozier
摘要
The extravascular implantable cardioverter–defibrillator (ICD) has a single lead implanted substernally to enable pause-prevention pacing, antitachycardia pacing, and defibrillation energy similar to that of transvenous ICDs. The safety and efficacy of extravascular ICDs are not yet known.